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Abstract
The long association and intense competition between bacteria and their viruses 
have created a fertile ground for evolution to develop numerous tools for DNA 
modification, assembly and degradation. Many of these tools underpin the past 
50 years of molecular biology, and others show great potential in shaping the next 
50 years of the field. Here, I present some of the tools that have come out of the 
bacteria-bacteriophage arms race and discuss some of the concepts that may shape 
their future use. Molecular biology remains a fast-growing area increasingly limited 
solely by researcher ingenuity.
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1. Introduction
The relationship between bacteriophages and bacteria is often explained in terms 
of an arms race: each ‘developing’ measures and countermeasures for attacking and 
defending itself from the other [1, 2]. The imagery of an arms race is a powerful 
metaphor to summarise the relationship between possibility and availability that 
have constrained the emergence, evolution and diversification of life on Earth.
Life is limited by what is possible. For instance, life can only exist because 
chemical information storage is possible. On the other hand, life as we know it has 
evolved around DNA and RNA because they are informational molecules that could 
function in the environment of the early Earth and whose building blocks were 
readily available.
The relationship between bacteria and bacteriophages is similarly constrained. 
The emergence (or availability) of bacterial cells capable of establishing a rich 
internal environment (compared to the outside of the cell) creates the possibility 
for other organisms to evolve predatory or parasitic survival strategies, including 
bacteriophages. Once phages emerge, they alter the dynamics of the ecological 
niche and create an advantage to bacterial hosts that can reduce the success of phage 
infection—whether by hindering phage access to the cell cytoplasm, by interfering 
with phage survival or replication in the cell or by interfering with phage matura-
tion and release [3].
Bacterial defences arise from any function already available in the 
host (e.g. uracil-DNA glycosylase involved in DNA repair) or that can be 
 co-opted from available genetic resources in the cell or in the environment 
Bacteriophages - Perspectives and Future
2
(e.g. restriction-modification systems). Defences can also emerge from loss of 
function (e.g. mutations to the maltose porin LamB in E. coli, which make it 
resistant to bacteriophage λ infections [4]).
Given the prevalence of bacteria and phages in the environment, and given the 
evolutionary scale time of their arms race, the variety, complexity and efficiency of 
these attack and defence strategies are huge and can range from silent integration into 
the host genome (i.e. lysogeny) to enacting a hostile molecular takeover of the bacte-
rial host cell. Despite our current efforts to map the genetic diversity available on 
Earth, it remains likely that new strategies are still to be identified and characterised.
Nonetheless, many of these defence and attack strategies have also been 
harnessed for biotechnology applications, significantly beyond the simple use 
of bacteriophages (or bacteriophage proteins) as bacterial control agents [5–7]. 
Restriction-modification (RM) systems found in bacteria were among the very 
first tools isolated from the bacteria-phage arms race [8, 9]. They de facto represent 
the start of modern molecular biology, and they have remained key tools for over 
50 years (Figure 1).
More recently, another tool derived from bacterial defence has been harnessed, 
with potentially equally transformative impact on how we interact with biology: 
clustered regularly interspersed palindromic repeats (CRISPR) [26–28]. CRISPR 
forms part of an adaptive immunity system in prokaryotes, but it is being harnessed 
to deliver a wide range of research and therapeutic tools.
Although RM systems and CRISPR are deservedly acknowledged as having a 
significant impact on molecular biology and biotechnology, many other tools have 
been or are being developed based on components isolated from the bacteria-phage 
arms race. This chapter focuses on some of those tools—their mechanisms, current 
and potential applications.
Figure 1. 
Potential biotechnology applications derived from bacteriophages. Almost every aspect of the bacteriophage 
life cycle can be exploited for the development of biotechnology tools. Aside from their natural bactericidal 
role, phages can be used for the delivery of engineered circuits [10, 11] and in directed evolution through phage 
display [12] and PACE [13]. Individual phage systems have been also successfully developed as tools.
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2. Common molecular biology tools and orthogonality
Because of the wide range of bacteriophage infection strategies available, it 
becomes difficult to introduce simple classification without recreating the complex-
ity of approaches taken by phages. For instance, bacteriophage promoters can rely 
exclusively on host proteins (e.g. T4 early promoters), on a mixture of host and 
phage proteins (e.g. T4 middle promoters or PL promoter from λ phage) or exclu-
sively on phage-derived factors (e.g. T7 RNA polymerase promoters). This provides 
a continuum that can be further dissected by analysing the mechanism of the 
hybrid promoters, with their specific host and phage dependencies.
That continuum maps how independent a phage system is from the host while 
still active within the host, i.e. it is a measure of the orthogonality of the system. 
Having evolved to survive in a changing environment, bacteria have complex 
layers of gene expression regulation with multiple feedback systems which are not 
necessarily easy to control independently, despite our advances in understanding 
bacterial metabolism [29, 30]. In that context, phage systems that have reduced 
dependencies on the host machinery (i.e. increased orthogonality) provide isolated 
systems that can be simpler to regulate and are, at least in part, shielded from varia-
tions in the cellular machinery—an approach that has dominated biotechnology 
until recently.
Many of the common phage-derived biotechnology tools have been developed 
from such systems, none more so than T7 RNA polymerase [31]. Isolated from T7 
bacteriophage, this monomeric RNA polymerase can recognise a specific promoter 
sequence. The core T7 promoter sequence (TAATACGACTCACTATAG) is suf-
ficient to trigger transcription in cells harbouring a T7 RNA polymerase gene. 
This is the strategy set up behind pET vectors, which contain a T7 promoter and 
rely on an E. coli host carrying a T7 RNA polymerase under an inducible promoter 
(e.g. lacUV)—usually the result of the introduction of a DE3 phage [32, 33].
Nevertheless, the context of the T7 promoter can have a significant impact on 
the expression level of the downstream genes, and at high polymerase concentra-
tions, it is possible to drive transcription from suboptimal promoters—highlighting 
that the orthogonality of the system is limited.
Given its monomeric structure and orthogonal role in cellular transcription, 
T7 RNA polymerase became not only a useful tool in biotechnology but also an 
important model system for the study of transcription (reviewed in [34]). Because 
of its orthogonality, T7 RNA polymerase (and its promoter) can be harnessed for 
the regulation of transcription in a wide range of hosts beyond E. coli, including 
Gram-positive bacterial hosts [35], yeast [36, 37] and human cells [38, 39].
Its role in the regulation of transcription has also been expanded through 
the creation of more complex systems using split T7 RNA polymerase proteins. 
Surprisingly for a mesophilic highly dynamic enzyme, T7 RNA polymerase can be 
expressed in two [40, 41] or more [42] fragments that in vivo are able to reassemble 
and function as viable RNA polymerases.
While orthogonality can be a desirable feature for in vivo applications, it is 
wholly unnecessary for in vitro applications, where the key constraint lies on iden-
tifying reaction conditions in which expressed and purified proteins are sufficiently 
active to carry out the desired function. That is the case with T4 DNA ligase and T4 
polynucleotide kinase, which were originally isolated from the E. coli T4 phage and 
remain important tools in molecular biology.
T4 DNA ligase has a central role in the replication and repair of the phage 
genome during its infection of E. coli [43]. This also entails coping with DNA 
modifications such as the full substitution of cytosine for 5-hydroxymethylcytosine 
and glucosyl-5-hydroxymethylcytosine that naturally occurs in vivo [44, 45]—this 
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is a phage defence mechanism discussed below. Although its structure has only 
recently been determined [46], the mechanism of action of this enzyme has long 
been characterised [47]. Even in the absence of other phage genes, it is active in vivo 
[48], but its main application in molecular biology remains its in vitro activity 
that, coupled with restriction endonucleases, has underpinned modern molecular 
 biology—allowing a molecular cut and paste approach to DNA assembly.
Ligase in vitro activity, particularly its ability to accept modified ligands, has 
been extensively explored for the assembly of heavily modified DNA sequences for 
aptamer selection [49, 50] and to explore a wider range of nucleic acid modifica-
tions, such as sugar-modified nucleic acids [51].
3. Second-generation tools and applications
The combination of different enzymatic functions has created novel applica-
tions, such as the large-scale DNA assembly in Gibson assembly through the combi-
nation of exonuclease, polymerase and ligase activities [52]. However, a whole range 
of novel applications are possible by harnessing additional bacteriophage proteins 
that have not yet been extensively explored.
Recombinases and integrases, enzymes that catalyse the sequence-specific inser-
tion of a phage genome into the host chromosome [53, 54], were identified early in 
bacteriophage research (e.g. the λ integrase) but were not immediately harnessed 
for applications. These came substantially later once recombinases were shown to 
facilitate DNA assembly, whether by increasing the efficiency of subcloning such 
as in Gateway cloning [55], or enabling multipart assemblies needed for metabolic 
engineering [56].
In general, recombinases bind DNA specifically, as dimers, on recognition 
sites that are relatively short (usually between 30 and 50 bases) and partially 
palindromic, termed attP and attB (originally to distinguish phage and bacterial 
origins). These two sites have different sequences which contribute to making 
the recombination process unidirectional. The recombinases facilitate the break 
and religation of double-stranded DNA within the att sites resulting in chimeric 
sites that are then labelled attR and attL (from right and left sides, respectively). 
Insertion of a phage genome into the host is efficient and stable, but it can also be 
reversed with the contribution of a single host factor (reviewed in [57]).
Because of the high efficiency of integration, recombinases have been also 
developed as systems to facilitate homologous recombination in higher eukaryotes, 
such as mammalian cells [58], Drosophila organisms [59] and plants (reviewed in 
[60]). In the latter, recombinases were of particular interest because of their poten-
tial to remove transformation and selection markers from engineered crops, leaving 
behind only the genes responsible for the engineered trait. This idea of using recom-
binases to directly alter an organism’s genome has been vastly expanded in the Yeast 
2.0 project, through the design implementation of multiple loxP (the equivalent to 
att sites for Cre recombinase) in the synthetic yeast genome that can be activated, 
leading to large-scale genome rearrangement—termed synthetic chromosome rear-
rangement and modification by loxP-mediated evolution (SCRaMbLE) [61].
By enabling controllable chromosome rearrangements between the designed 
loxP sites, a synthetic yeast can delete, duplicate and reorder many of its genes, 
allowing in vivo selection for desirable traits such as increased alkali tolerance [62]. 
Alternatively, the system can be coupled to heterologously expressed genes allowing 
the rapid optimisation of pathways [63].
Like SCRaMbLE, protein-directed evolution relies on cycles of mutagenesis (to 
introduce diversity into a population) and selection (to reduce diversity towards 
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functional proteins) [64] which in some platforms can be achieved continuously 
in vivo—e.g. in PACE [13] or in some continuous culture approaches [65]. In both 
examples, mutation can be controlled by stressors or the induction of error-prone 
replication but are not necessarily limited to the area of interest (e.g. a single gene). 
Greater control of targeting is possible and has been reported through the use of 
an error-prone PolI [66]—which is necessary for the replication of some bacterial 
plasmids and can be used to drive diversification in vivo in the vicinity of plasmid 
replication initiation—and protein fusions that target an error-prone polymerase to 
a particular region of the genome [e.g. EvolvR and MutaT7 (reviewed in [67])].
However, one such system, termed diversity-generating retroelements (DGRs), 
has naturally emerged in bacteriophages and was first implicated in the tropism 
switching of Bordetella phages [68, 69] but that has since been identified in a 
wide range of bacterial and archaeal genomes [70, 71]. The system relies on an 
error-prone reverse transcriptase (RT) and on two DNA repeats—one operat-
ing as a template (template repeat) and the other as the target (variable repeat). 
RNA synthesised from the template is used to guide the error-prone synthesis of 
a DNA by the RT, which also coordinates its insertion at the target site. The error-
profile of DGR RTs results in adenines being replaced with other bases, creating a 
directionality to the evolution that is always anchored by the template repeat [72]. 
Nevertheless, changes in DNA sequences involved in the targeting of the retroele-
ment, termed initiation of mutagenic homing (IMH), can lead to both template 
and variable repeats being allowed to evolve at different rates—removing some of 
the directionality in evolution and freeing the system to explore the sequence space 
more thoroughly [68].
Despite its potential, it remains to be seen whether such a system can be har-
nessed for protein engineering. If the DGR systems can themselves be engineered, 
their targeting and error rate may be amenable to modulation opening possibilities 
to compete with the most recent Cas9-derived gene editors [73].
4. Xenobiotic nucleic acids
Chemical modification of the phage’s own genome is a widespread strategy that 
emerged multiple times in evolution to circumvent (or at least slow down) bacte-
rial defence mechanisms that target the invading DNA for degradation: restriction 
endonucleases, exonucleases and CRISPR-Cas systems [44, 74]. Those modifica-
tions have been reported not only on the nucleobases, akin to eukaryotic epigenetic 
markers, but also on the nucleic acid backbone.
Reported nucleobase modifications suggest that the overwhelming majority of 
any such modifications is targeted to the C5 position in pyrimidines. They range 
from small modifications, such as methylation, to bulky modifications, such as 
putrescine and even carbohydrate moieties. While such modifications have long 
been known, new sequencing platforms capable of reading the DNA sequence 
without an amplification step, such as nanopore sequencing, hold great promise in 
enabling a more systematic mapping and characterisation of DNA modifications in 
phage genomes (Figure 2) [75].
DNA modifications, particularly modifications that bring chemical functional-
ity not available in natural bases, such as glycosylation in Bacillus subtilis SP-15 
phage [76], can be harnessed for function as has been achieved through the chemi-
cal modification of DNA bases and systematic evolution of ligands by exponential 
enrichment (SELEX) [50, 77]. Despite characterisation of the biosynthetic pathway 
for multiple-phage DNA modification systems, none have been implemented 
in vitro for applications.
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One potential bottleneck lies on how the phage and the host handle those chemi-
cally modified DNAs. Upon infection, the mature phage DNA needs to be modified 
if that is an evolutionary strategy being exploited to slow down or avoid in vivo 
degradation. On the other hand, those chemical modifications can affect DNA 
structure and biophysical properties which may also be detrimental to bacterio-
phage replication—since this would require a DNA polymerase capable of process-
ing such heavily modified genomes.
It is known that at least in some cases, this chemical cloaking is removed upon infec-
tion, such as in SP-15 [78], before unmodified DNA is replicated in vivo. But, given viral 
polymerases more permissive substrate specificity, it is possible that some systems can 
be replicated directly by highly adapted phage polymerases—either to DNA followed 
by reinstalling the chemical modifications or directly from modified DNA to modi-
fied DNA. In the case of SP-15, the bulkier modifications are rapidly removed prior 
to replication of DNA [78]. T4 seems to follow a similar pattern where glycosylation is 
removed, and DNA is replicated containing only the simpler 5-hydroxymethylation 
modification. This is further supported by the biochemical evidence that glycosylation 
is ‘installed’ on the replicated T4 DNA [44, 74]. Nevertheless, early T4 transcription 
occurs rapidly, and it is carried out by the host RNA polymerase, suggesting that 
natural RNA polymerases can still use the hypermodified bases in that template.
Notably, although phage polymerases replicate phage DNA in vivo harbouring 
simple chemical modifications, such as (in Synechocystis S-2 L phage) 2-amino-
adenine [79] and uracil (in Bacillus phages AR9, PBS1 and PBS2, Yersinia phage 
PhiR1-37 and Staphylococcus phage S6), no viral polymerase has been described 
that is capable of selectively incorporating the modified bases. That is, although 
some bacteriophages make use of modified nucleobases and have evolved systems 
that lead to 100% incorporation of the modified bases in their genomes, their DNA 
polymerases have not specialised towards being able to only incorporate the modi-
fied nucleobases—they remain able to recognise unmodified triphosphates.
Figure 2. 
Examples of XNAs in phages. Nucleobases are composed of three different chemical moieties, and change to any 
one of them has the potential to alter duplex conformation and how easily they are recognised by natural nucleic 
acid processing enzymes [14–25]. The base, sugar and backbone discussed in the chapter are shown here.
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Still, the increased substrate flexibility of phage DNA polymerases may at least 
in part justify why a Bacillus subtilis Phi29 DNA polymerase required a single muta-
tion for the synthesis of anhydrohexitol nucleic acids (HNA) [80] while an archaeal 
enzyme required in excess of seven mutations [81].
5. Conclusion
Bacteriophages remain a rich source of novel functionalities that can be har-
nessed to advance molecular biology (and synthetic biology). The examples here 
provided represent only a small fraction of the potential applications available, 
which also include medical applications from phage proteins [82, 83] and engi-
neered phages [10, 11, 84].
In addition, bacteriophages have had a close relationship with directed evolu-
tion, either as a vehicle such as in phage display [85, 86] or by providing (in addition 
to the examples above) proteins to accelerate strain engineering, such as in multi-
plex automated genome engineering (MAGE) [87].
Finally, bacteriophages may also become an important tool in harnessing new 
non-model organisms in synthetic biology, as pre-optimised DNA delivery nano-
machines for custom circuits.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
8Bacteriophages - Perspectives and Future
[1] Koonin EV, Makarova KS, Wolf YI. 
Evolutionary genomics of defense 
systems in Archaea and Bacteria. 
Annual Review of Microbiology. 
2017;71(1):233-261. DOI: 10.1146/
annurev-micro-090816-093830
[2] Labrie SJ, Samson JE, Moineau S. 
Bacteriophage resistance mechanisms. 
Nature Reviews. Microbiology. 
2010;8:317. DOI: 10.1038/nrmicro2315
[3] Seed KD. Battling phages: How 
bacteria defend against viral attack. 
PLoS Pathogens. 2015;11(6):e1004847. 
DOI: 10.1371/journal.ppat.1004847
[4] Chatterjee S, Rothenberg E. 
Interaction of bacteriophage l with 
Its E. coli receptor, LamB. Viruses. 
2012;4:3162-3178
[5] Lemire S, Yehl KM, Lu TK. Phage-
based applications in synthetic 
biology. Annual Review of Virology. 
2018;5(1):453-476. DOI: 10.1146/
annurev-virology-092917-043544
[6] Salmond GPC, Fineran PC. A 
century of the phage: Past, present and 
future. Nature Reviews. Microbiology. 
2015;13:777. DOI: 10.1038/nrmicro3564
[7] Kortright KE, Chan BK, 
Koff JL, Turner PE. Phage therapy: 
A renewed approach to combat 
antibiotic-resistant bacteria. Cell 
Host & Microbe. 2019;25(2):219-
232. Available from: https://www.
sciencedirect.com/science/article/pii/
S1931312819300526?via%3Dihub
[8] Tock MR, Dryden DTF. The biology 
of restriction and anti-restriction. 
Current Opinion in Microbiology. 
2005;8(4):466-472
[9] Pingoud A, Wilson GG, Wende W. 
Type II restriction endonucleases—A 
historical perspective and more. Nucleic 
Acids Research. 2014;42(12):7489-7527. 
DOI: 10.1093/nar/gku447
[10] Ando H, Lemire S, Pires DP, 
Lu TK. Engineering modular viral 
scaffolds for targeted bacterial 
population editing. Cell Systems. 
2015;1(3):187-196
[11] Bikard D, Euler CW, Jiang W, 
Nussenzweig PM, Goldberg GW, 
Duportet X, et al. Exploiting CRISPR-
cas nucleases to produce sequence-
specific antimicrobials. Nature 
Biotechnology. 2014;32(11):1146-1150
[12] Fernandez-Gacio A, Uguen M, 
Fastrez J. Phage display as a tool for the 
directed evolution of enzymes. Trends 
in Biotechnology. 2003;21(9):408-414
[13] Esvelt KM, Carlson JC, Liu DR. A 
system for the continuous directed 
evolution of biomolecules. Nature. 
2011;472(7344):499. DOI: 10.1038/
nature09929
[14] Moon J-S, Kim W-G, Kim C, 
Park G-T, Heo J, Yoo SY, et al. M13 
bacteriophage-based self-assembly 
structures and their functional 
capabilities. Mini-Reviews in Organic 
Chemistry. 2015;12(3):271-281
[15] Han J, Devaraj V, Kim C, Kim W-G, 
Han D-W, Hong SW, et al. Fabrication 
of self-assembled nanoporous 
structures from a self-templating M13 
bacteriophage. ACS Applied Nano 
Materials. 2018;1(6):2851-2857. DOI: 
10.1021/acsanm.8b00500
[16] Krupovic M, Koonin EV. Multiple 
origins of viral capsid proteins from 
cellular ancestors. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
2017;114(12):E2401-E2410
[17] Wang I-N, Smith DL, 
Young R. Holins: The protein clocks 
of bacteriophage infections. 
Annual Review of Microbiology. 
2000;54(1):799-825
References
9Biotechnology Tools Derived from the Bacteriophage/Bacteria Arms Race
DOI: http://dx.doi.org/10.5772/intechopen.90367
[18] Denyes JM, Dunne M, Steiner S, 
Mittelviefhaus M, Weiss A, Schmidt H, 
et al. Modified bacteriophage S16 long 
tail fiber proteins for rapid and specific 
immobilization and detection 
of Salmonella cells. Applied and 
Environmental Microbiology. 
2017;83(12):e00277-17
[19] Schmelcher M, Loessner MJ. 
Bacteriophage: Powerful tools for 
the detection of bacterial pathogens. 
In: Principles of Bacterial Detection: 
Biosensors, Recognition Receptors 
and Microsystems. New York: 
Springer; 2008. p. 731-754. 
ISBN: 978-0-387-75112-2
[20] Dunne M, Loessner MJ. Modified 
bacteriophage tail fiber proteins for 
labeling, immobilization, capture, 
and detection of bacteria. Methods in 
Molecular Biology. 2019;1918:67-86
[21] Ravikumar A, Arrieta A, Liu CC. An 
orthogonal DNA replication system 
in yeast. Nature Chemical Biology. 
2014;10(3):175-177
[22] Mencía M, Gella P, Camacho A, 
de Vega M, Salas M. Terminal protein-
primed amplification of heterologous 
DNA with a minimal replication 
system based on phage Phi29. 
Proceedings of the National Academy 
of Sciences of the United States 
of America. 2011;108(46):18655-
18660. Available from: http://www.
pubmedcentral.nih.gov/articlerender.
fcgi?artid=3219123&tool=pmcentrez&
rendertype=abstract
[23] Carr PA, Wang HH, Sterling B, 
Isaacs FJ, Lajoie MJ, Xu G, et al. 
Enhanced multiplex genome 
engineering through co-operative 
oligonucleotide co-selection. Nucleic 
Acids Research. 2012;40(17):e132
[24] Serrano-Heras G, Ruiz-Masó JA, 
Del Solar G, Espinosa M, Bravo A, 
Salas M. Protein p56 from the Bacillus 
subtilis phage Φ29 inhibits DNA-binding 
ability of uracil-DNA glycosylase. 
Nucleic Acids Research. 
2007;34(16):5393-5401
[25] Thompson LR, Zeng Q , Kelly L, 
Huang KH, Singer AU, Stubbe JA, et al. 
Phage auxiliary metabolic genes and 
the redirection of cyanobacterial host 
carbon metabolism. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
2011;108(39):E757-E764
[26] Lander ES. The heroes of CRISPR. 
Cell. 2016;164(1-2):18-28. Available 
from: https://www.sciencedirect.com/
science/article/pii/S0092867415017055?
via%3Dihub#bib34
[27] Mojica FJM, Juez G, Rodriguez- 
Valera F. Transcription at different 
salinities of Haloferax mediterranei 
sequences adjacent to partially modified 
PstI sites. Molecular Microbiology. 
1993;9(3):613-621. DOI: 10.1111/j.1365-
2958.1993.tb01721.x
[28] Jansen R, Embden JDA van, 
Gaastra W, Schouls LM. Identification 
of genes that are associated with DNA 
repeats in prokaryotes. Molecular 
Microbiology. 2002;43(6):1565-1575. 
DOI: 10.1046/j.1365-2958.2002.02839.x
[29] Gibson DG, Benders GA, 
Andrews-Pfannkoch C, 
Denisova EA, Baden-Tillson H, Zaveri J, 
et al. Complete chemical synthesis, 
assembly, and cloning of a mycoplasma 
genitalium genome. Science. 
2008;319(5867):1215-1220
[30] Orth JD, Conrad TM, Na J, 
Lerman JA, Nam H, Feist AM, et al. 
A comprehensive genome-scale 
reconstruction of Escherichia coli 
metabolism-2011. Molecular Systems 
Biology. 2011;7(1):535
[31] Tabor S, Richardson CC. A 
bacteriophage T7 RNA polymerase/
promoter system for controlled 
exclusive expression of specific genes. 
Bacteriophages - Perspectives and Future
10
Proceedings of the National Academy 
of Sciences of the United States of 
America. 1985;82(4):1074-1078
[32] Rosenberg AH, Lade BN, Dao-
shan C, Lin SW, Dunn JJ, Studier FW. 
Vectors for selective expression of 
cloned DNAs by T7 RNA polymerase. 
Gene. 1987;56(1):125-135
[33] Giordano TJ, Deuschle U, Bujard H, 
McAllister WT. Regulation of coliphage 
T3 and T7 RNA polymerases by the 
lac represser-operator system. Gene. 
1989;84(2):209-219
[34] Sousa R. T7 RNA polymerase. In: 
Encyclopedia of Biological Chemistry. 
2nd ed. Elsevier; 2013. p. 355-359. ISBN: 
9780123786319
[35] Kortmann M, Kuhl V, Klaffl S, 
Bott M. A chromosomally encoded 
T7 RNA polymerase-dependent gene 
expression system for Corynebacterium 
glutamicum: Construction and 
comparative evaluation at the single-
cell level. Microbial Biotechnology. 
2015;8(2):253-265
[36] Hobl B, Hock B, Schneck S, 
Fischer R, Mack M. Bacteriophage T7 
RNA polymerase-based expression in 
Pichia pastoris. Protein Expression and 
Purification. 2013;92(1):100-104
[37] Benton BM, Eng WK, 
Dunn JJ, Studier FW, Sternglanz R, 
Fisher PA. Signal-mediated import of 
bacteriophage T7 RNA polymerase into 
the Saccharomyces cerevisiae nucleus 
and specific transcription of target 
genes. Molecular and Cellular Biology. 
1990;10(1):353-360
[38] Aoki Y, Aizaki H, Shimoike T,  
Tani H, Ishii K, Saito I, et al. A 
human liver cell line exhibits 
efficient translation of HCV RNAs 
produced by a recombinant adenovirus 
expressing T7 RNA polymerase. 
Virology. 1998;250(1):140-150
[39] Dunn JJ, Krippl B, Bernstein KE, 
Westphal H, William SF. Targeting 
bacteriophage T7 RNA polymerase to 
the mammalian cell nucleus. Gene. 
1988;68(2):259-266
[40] Schaerli Y, Gili M, Isalan M. A 
split intein T7 RNA polymerase 
for transcriptional AND-
logic. Nucleic Acids Research. 
2014;42(19):12322-12328
[41] Shis DL, Bennett MR. Library 
of synthetic transcriptional AND 
gates built with split T7 RNA 
polymerase mutants. Proceedings of 
the National Academy of Sciences 
of the United States of America. 
2013;110(13):5028-5033
[42] Segall-Shapiro TH, Meyer AJ, 
Ellington AD, Sontag ED, Voigt CA. A 
‘resource allocator’ for transcription 
based on a highly fragmented T7 RNA 
polymerase. Molecular Systems Biology. 
2014;10(7):742
[43] Mueser TC, Hinerman JM, 
Devos JM, Boyer RA, Williams KJ. 
Structural analysis of bacteriophage 
T4 DNA replication: A review in the 
virology journal series on bacteriophage 
T4 and its relatives. Virology Journal. 
2010;7(1):359
[44] Weigele P, Raleigh EA. Biosynthesis 
and function of modified bases in 
bacteria and their viruses. Chemical 
Reviews. 2016;116(20):12655-12687
[45] Vlot M, Houkes J, SJA L, Swarts DC, 
Zheng P, Kunne T, et al. Bacteriophage 
DNA glucosylation impairs target 
DNA binding by type I and II but 
not by type V CRISPR–Cas effector 
complexes. Nucleic Acids Research. 
2018;46(2):873-885
[46] Shi K, Bohl TE, Park J, Zasada A, 
Malik S, Banerjee S, et al. T4 DNA 
ligase structure reveals a prototypical 
ATP-dependent ligase with a 
unique mode of sliding clamp 
11
Biotechnology Tools Derived from the Bacteriophage/Bacteria Arms Race
DOI: http://dx.doi.org/10.5772/intechopen.90367
interaction. Nucleic Acids Research. 
2018;46(19):10474-10488
[47] Rossi R, Montecucco A, 
Ciarrocchi G, Biamonti G. Functional 
characterization of the T4 DNA ligase: 
A new insight into the mechanism 
of action. Nucleic Acids Research. 
1997;25(11):2106-2113
[48] Su T, Liu F, Chang Y, Guo Q , 
Wang J, Wang Q , et al. The phage 
T4 DNA ligase mediates bacterial 
chromosome DSBs repair as single 
component non-homologous end 
joining. Synthetic and Systems 
Biotechnology. 2019;4(2):107-112
[49] Hili R, Niu J, Liu DR. DNA ligase-
mediated translation of DNA into 
densely functionalized nucleic acid 
polymers. Journal of the American 
Chemical Society. 2013;135(1):98-101. 
DOI: 10.1021/ja311331m
[50] Kong D, Yeung W, 
Hili R. In vitro selection of diversely 
functionalized aptamers. Journal 
of the American Chemical Society. 
2017;139(40):13977-13980
[51] Kestemont D, Renders M, 
Leonczak P, Abramov M, Schepers G, 
Pinheiro VB, et al. XNA ligation using 
T4 DNA ligase in crowding conditions. 
Chemical Communications. 
2018;54(49):6408-6411. DOI: 10.1039/
C8CC02414F
[52] Gibson DG, Young L, Chuang 
R-Y, Venter JC, Hutchison CA, 
Smith HO. Enzymatic assembly of 
DNA molecules up to several hundred 
kilobases. Nature Methods. 
2009;6(5):343-345
[53] Landy A. The λ integrase site-specific 
recombination pathway. In: Mobile DNA 
III. American Society of Microbiology; 
2015. p. 91-118. ISSN: 2165-0497
[54] Groth AC, Calos MP. Phage 
integrases: Biology and applications. 
Journal of Molecular Biology. 
2004;335(3):667-678
[55] Hartley JL, Temple GF, Brasch MA. 
DNA cloning using in vitro site-specific 
recombination. Genome Research. 
2000;10(11):1788-1795
[56] Colloms SD, Merrick CA, 
Olorunniji FJ, Stark WM, Smith MCM, 
Osbourn A, et al. Rapid metabolic 
pathway assembly and modification 
using serine integrase site-specific 
recombination. Nucleic Acids Research. 
2014;42(4):e23
[57] Rutherford K, Van Duyne GD. The 
ins and outs of serine integrase site-
specific recombination. Current 
Opinion in Structural Biology. 
2014;24:125-131
[58] Thyagarajan B, Olivares EC, 
Hollis RP, Ginsburg DS, Calos MP. Site-
specific genomic integration in 
mammalian cells mediated by phage 
φC31 integrase. Molecular and Cellular 
Biology. 2001;21(12):3926-3934
[59] Groth AC, Fish M, Nusse R, 
Calos MP. Construction of transgenic 
Drosophila by using the site-specific 
integrase from phage φC31. Genetics. 
2004;166(4):1775-1782
[60] Ow DW. The long road to 
recombinase-mediated plant 
transformation. Plant Biotechnology 
Journal. 2016;14(2):441-447
[61] Shen Y, Stracquadanio G, 
Wang Y, Yang K, Mitchell LA, Xue Y, 
et al. SCRaMbLE generates designed 
combinatorial stochastic diversity 
in synthetic chromosomes. Genome 
Research. 2016;26(1):36-49
[62] Ma L, Li Y, Chen X, Ding M, Wu Y, 
Yuan YJ. SCRaMbLE generates evolved 
yeasts with increased alkali tolerance. 
Microbial Cell Factories. 2019;18(1):52
[63] Liu W, Pham NT, Tuck L, Pérez-Pi I, 
Shen Y, French C, et al. Rapid pathway 
Bacteriophages - Perspectives and Future
12
prototyping and engineering using 
in vivo and in vivo synthetic genome 
SCRaMbLE-in methods. Nature 
Communications. 2018;9(1):1936
[64] Tizei PAG, Csibra E, Torres L, 
Pinheiro VB. Selection platforms for 
directed evolution in synthetic biology. 
Biochemical Society Transactions. 
2016;44(4):1165-1175. DOI: 10.1042/
BST20160076
[65] Marlière P, Patrouix J, Döring V, 
Herdewijn P, Tricot S, Cruveiller S, et al. 
Chemical evolution of a bacterium’s 
genome. Angewandte Chemie, 
International Edition. 
2011;50(31):7109-7114
[66] Camps M, Naukkarinen J, 
Johnson BP, Loeb LA. Targeted gene 
evolution in Escherichia coli using a 
highly error-prone DNA polymerase I. 
Proceedings of the National Academy 
of Sciences of the United States of 
America. 2003;100(17):9727-9732
[67] Yang J, Kim B, Kim GY, 
Jung GY, Seo SW. Synthetic biology 
for evolutionary engineering: From 
perturbation of genotype to acquisition 
of desired phenotype. Biotechnology for 
Biofuels. 2019;12(1):113
[68] Doulatov S, Hodes A, Dal L, 
Mandhana N, Liu M, Deora R, et al. 
Tropism switching in Bordetella 
bacteriophage defines a family of 
diversity-generating retroelements. 
Nature. 2004;431(7007):476-481
[69] Liu M, Deora R, Doulatov SR, 
Gingery M, Eiserling FA, Preston A, 
et al. Reverse transcriptase-mediated 
tropism switching in Bordetella 
bacteriophage. Science. 
2002;295(5562):2091-2094
[70] Paul BG, Burstein D, Castelle CJ, 
Handa S, Arambula D, Czornyj E, 
et al. Retroelement-guided protein 
diversification abounds in vast lineages 
of bacteria and archaea. Nature 
Microbiology. 2017;2(6):17045
[71] Paul BG, Bagby SC, Czornyj E, 
Arambula D, Handa S, Sczyrba A, 
et al. Targeted diversity generation by 
intraterrestrial archaea and archaeal 
viruses. Nature Communications. 
2015;6(1):6585
[72] Guo H, Tse LV, Barbalat R, 
Sivaamnuaiphorn S, Xu M, Doulatov S, 
et al. Diversity-generating retroelement 
homing regenerates target sequences for 
repeated rounds of codon rewriting and 
protein diversification. Molecular Cell. 
2008;31(6):813-823
[73] Anzalone AV, Randolph PB, 
Davis JR, Sousa AA, Koblan LW, 
Levy JM, et al. Search-and-replace 
genome editing without double-
strand breaks or donor DNA. Nature. 
2019;576(7785):149-157. DOI: 10.1038/
s41586-019-1711-4
[74] Warren RAJ. Modified bases in 
bacteriophage DNAs. Annual Review of 
Microbiology. 1980;34(1):137-158
[75] Liu Q , Fang L, Yu G, Wang D, 
Xiao C-L, Wang K. Detection of DNA 
base modifications by deep recurrent 
neural network on Oxford 
nanopore sequencing data. Nature 
Communications. 2019;10(1):2449. 
DOI: 10.1038/s41467-019-10168-2
[76] Ehrlich M, Ehrlich KC. A novel, 
highly modified, bacteriophage DNA in 
which thymine is partly replaced by a 
phosphoglucuronate moiety covalently 
bound to 5-(4′,5′-dihydroxypentyl)
uracil. The Journal of Biological 
Chemistry. 1981;256(19):9966-9972
[77] Davies DR, Gelinas AD, Zhang C, 
Rohloff JC, Carter JD, O’Connell D, 
et al. Unique motifs and hydrophobic 
interactions shape the binding of 
modified DNA ligands to protein targets. 
Proceedings of the National Academy 
of Sciences. 2012;109(49):19971-19976. 
DOI: 10.1073/pnas.1213933109
[78] Neubort S, Marmur J. Synthesis 
of the unusual DNA of Bacillus subtilis 
13
Biotechnology Tools Derived from the Bacteriophage/Bacteria Arms Race
DOI: http://dx.doi.org/10.5772/intechopen.90367
bacteriophage SP 15. Journal of Virology. 
1973;12(5):1078-1084
[79] Kirnos MD, Khudyakov IY, 
Alexandrushkina NI, Vanyushin BF. 
2-Aminoadenine is an adenine 
substituting for a base in S-2L 
cyanophage DNA. Nature. 
1977;270(5635):369-370
[80] Torres LL, Pinheiro VB. Xenobiotic 
nucleic acid (XNA) synthesis by Phi29 
DNA polymerase. Current Protocols in 
Chemical Biology. 2018;10(2):e41. DOI: 
10.1002/cpch.41
[81] Pinheiro VB, Taylor AI, Cozens C, 
Abramov M, Renders M, Zhang S, et al. 
Synthetic genetic polymers capable 
of heredity and evolution. Science. 
2012;336(6079):341-344. Available 
from: http://www.sciencemag.org/
content/336/6079/341%5Cnhttp://www.
ncbi.nlm.nih.gov/pubmed/22517858
[82] Saier MH, Reddy BL. Holins in 
bacteria, eukaryotes, and archaea: 
Multifunctional xenologues with 
potential biotechnological and biomedical 
applications. Journal of Bacteriology. 
2015;197(1):7-17. Available from: http://
jb.asm.org/content/197/1/7.abstract
[83] São-José C. Engineering of phage-
derived lytic enzymes: Improving their 
potential as antimicrobials. Antibiotics. 
2018;7(2):29
[84] Pires DP, Cleto S, Sillankorva S, 
Azeredo J, Lu TK. Genetically 
engineered phages: A review of 
advances over the last decade. 
Microbiology and Molecular Biology 
Reviews. 2016;80(3):523-543
[85] McCafferty J, Griffiths AD, 
Winter G, Chiswell DJ. Phage antibodies: 
Filamentous phage displaying antibody 
variable domains. Nature. 1990;348:552. 
DOI: 10.1038/348552a0
[86] Barbas CF, Kang AS, Lerner RA, 
Benkovic SJ. Assembly of combinatorial 
antibody libraries on phage surfaces: 
The gene III site. Proceedings of 
the National Academy of Sciences. 
1991;88(18):7978-7982. DOI: 10.1073/
pnas.88.18.7978
[87] Wang HH, Isaacs FJ, Carr PA, 
Sun ZZ, Xu G, Forest CR, et al. 
Programming cells by multiplex genome 
engineering and accelerated evolution. 
Nature. 2009;460(7257):894-898. DOI: 
10.1038/nature08187
